Abstract
Breast cancer and prostate cancer are the most common invasive types of cancers in women and men. Many of the recent advances in understanding the pathophysiology of breast and prostate cancers have paved the way for new treatment strategies. The alarming increase in the global cancer death toll has fueled the quest for new effective anti-tumor drugs through biological screening of both terrestrial and marine organisms. Recently, marine-derived natural bioactive products, isolated from aquatic fungi, cyanobacteria, sponges, algae, and tunicates, have been found to exhibit various anti-cancer activities including anti-angiogenic, anti-proliferative, inhibition of topoisomerase activities and induction of apoptosis. Thus, marine derived chemical derivatives such as alkaloids, macrolides, terpenes and other miscellaneous compounds possess anticancer properties. Hence, this review discusses the role of marine compounds on breast and prostate cancer.
Keywords: Alkaloids, breast, cancer, macrolides, prostate, spongistatin.
Current Bioactive Compounds
Title:Marine Derived Bioactive Compounds for Breast and Prostate Cancer Treatment: A Review
Volume: 10 Issue: 1
Author(s): Senthilkumar Kalimuthu, Jayachandran Venkatesan and Se-Kwon Kim
Affiliation:
Keywords: Alkaloids, breast, cancer, macrolides, prostate, spongistatin.
Abstract: Breast cancer and prostate cancer are the most common invasive types of cancers in women and men. Many of the recent advances in understanding the pathophysiology of breast and prostate cancers have paved the way for new treatment strategies. The alarming increase in the global cancer death toll has fueled the quest for new effective anti-tumor drugs through biological screening of both terrestrial and marine organisms. Recently, marine-derived natural bioactive products, isolated from aquatic fungi, cyanobacteria, sponges, algae, and tunicates, have been found to exhibit various anti-cancer activities including anti-angiogenic, anti-proliferative, inhibition of topoisomerase activities and induction of apoptosis. Thus, marine derived chemical derivatives such as alkaloids, macrolides, terpenes and other miscellaneous compounds possess anticancer properties. Hence, this review discusses the role of marine compounds on breast and prostate cancer.
Export Options
About this article
Cite this article as:
Kalimuthu Senthilkumar, Venkatesan Jayachandran and Kim Se-Kwon, Marine Derived Bioactive Compounds for Breast and Prostate Cancer Treatment: A Review, Current Bioactive Compounds 2014; 10 (1) . https://dx.doi.org/10.2174/1573407210666140327212945
DOI https://dx.doi.org/10.2174/1573407210666140327212945 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
Call for Papers in Thematic Issues
Antioxidants: Unveiling Their Power in Health and Disease
Antioxidants have captured significant interest for decades due to their potential role in preventing chronic diseases. These molecules combat free radicals, unstable molecules that can damage cells and contribute to the development of conditions like metabolic diseases, heart disease, cancer, and neurodegenerative diseases. This thematic issue will explore the cutting-edge ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Pathogenic Role of Persistent Milk Signaling in mTORC1- and Milk- MicroRNA-Driven Type 2 Diabetes Mellitus
Current Diabetes Reviews Can γH2AX be Used to Personalise Cancer Treatment?
Current Molecular Medicine An Electrochemical Outlook on Tamoxifen Biotransformation: Current and Future Prospects
Current Drug Metabolism Anticancer Drugs Designed by Mother Nature: Ancient Drugs but Modern Targets
Current Pharmaceutical Design Neutrophil Elastase Inhibition: A New Cancer Therapy
Current Enzyme Inhibition Cancer Immunotherapy: The Role Regulatory T Cells Play and What Can be Done to Overcome their Inhibitory Effects
Current Molecular Medicine The Past, Current Studies and Future of Organometallic <sup>99m</sup>Tc(CO)3 Labeled Peptides and Proteins
Current Pharmaceutical Design In Silico Transcriptomic Analysis of the Chloride Intracellular Channels (CLIC) Interactome Identifies a Molecular Panel of Seven Prognostic Markers in Patients with Pancreatic Ductal Adenocarcinoma
Current Genomics Lipoxygenase Inhibitors as Cancer Chemopreventives: Discovery, Recent Developments and Future Perspectives
Current Medicinal Chemistry RAS Pathways in Prostate Cancer - Mediators of Hormone Resistance?
Current Cancer Drug Targets Chest Pain in Children
Current Pediatric Reviews Genomic Organization and Control of the Grb7 Gene Family
Current Genomics Oleamide Derivatives are Prototypical Anti-Metastasis Drugs that Act by Inhibiting Connexin 26
Current Drug Safety Biodistribution, Safety and Organ Toxicity of Docetaxel-Loaded in HER-2 Aptamer Conjugated Ecoflex® Nanoparticles in a Mouse Xenograft Model of Ovarian Cancer
Recent Patents on Nanotechnology Recent Advances in Coumarins and 1-Azacoumarins as Versatile Biodynamic Agents
Current Medicinal Chemistry CDC25 Phosphatase Inhibitors: An Update
Mini-Reviews in Medicinal Chemistry A Dual Mode Pulsed Electro-Magnetic Cell Stimulator Produces Acceleration of Myogenic Differentiation
Recent Patents on Biotechnology Intestinal Barrier Dysfunction in Human Pathology and Aging
Current Pharmaceutical Design Physiology of Immune System: Regulation of Stem Cell Survival
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Importance of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in Intratumoral Disposition of Anticancer Agents
Current Cancer Drug Targets